Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Not sure where everyone is getting the idea that the recent news means Purdue is pulling back from Oxy or it will help us in our litigation against them?

what the article stated was "they intend to pull back sales reps" from visiting doctors. This just means to me they are not going to as aggressively sell it. not that they will stop selling it or want to cut back on selling it.

with all the lawsuits out there, it makes sense they now want to handle questions doctors have in house rather than have 500 different people give out potentially 500 different answers.

The one benefit I see out of this is it gives competitors a leg up to start visiting doctors and possibly break into the market. but I do not see this in anyway as an indication of them pulling away from the drug.